绝经后女性患者骨密度程度和炎症因子的相关性
Correlation between Bone Mineral Density and Inflammatory Factors in Postmenopausal Women
DOI: 10.12677/ACM.2022.123338, PDF,   
作者: 于 洁, 张雪娟*:青岛大学附属医院,山东 青岛;鲁海山:青岛市即墨区南泉卫生院,山东 青岛
关键词: 炎症因子骨质疏松绝经Inflammatory Factors Osteoporosis Menopause
摘要: 目的:探讨绝经后患者骨密度程度和炎症因子的相关性。方法:选择138例2020年1月至2021年1月我院患者,根据骨密度水平分为骨质疏松组(n = 46),骨量减少组(n = 46)和对照组(n = 46),骨质疏松组:T值 ≤ −2.5,骨量减少组:−1 < T值 < −2.5,对照组:T值 ≥ −1.0,进行相关性分析。结果:HbA1c、TNF-α、IL-6对绝经后2型糖尿病性肾病合并骨质疏松患者病情有预测价值。结论:绝经后患者骨密度水平越差炎症因子水平越高。
Abstract: Objective: To investigate the correlation between bone mineral density and inflammatory factors in postmenopausal patients. Methods: 138 patients in our hospital from January 2020 to January 2021 were selected and divided into osteoporosis group (n = 46), bone mass reduction group (n = 46) and control group (n = 46) according to bone mineral density level. Osteoporosis group: T value ≤ −2.5, bone mass reduction group: −1 < T value < −2.5, control group: T value ≥ −1.0, the correlation analysis is conducted. Results: HbA1c, TNF-α and IL-6 have predictive value in postmenopausal patients with type 2 diabetic nephropathy complicated with osteoporosis. Conclusion: The lower the BMD level in postmenopausal patients, the higher the inflammatory factor level.
文章引用:于洁, 鲁海山, 张雪娟. 绝经后女性患者骨密度程度和炎症因子的相关性[J]. 临床医学进展, 2022, 12(3): 2348-2352. https://doi.org/10.12677/ACM.2022.123338

参考文献

[1] Johnell, O., Kanis, J.A., Oden, A., et al. (2005) Predictive Value of BMD for Hip and Other Fractures. Journal of Bone & Mineral Research, 20, 1185-1194. [Google Scholar] [CrossRef
[2] Odén, A., Mccloskey, E.V., Kanis, J.A., et al. (2015) Burden of High Fracture Probability Worldwide: Secular Increases 2010-2040. Osteoporosis International, 26, 2243-2248. [Google Scholar] [CrossRef] [PubMed]
[3] Raska, J.I., Rasková, M., Zikán, V., et al. (2017) Prevalence and Risk Factors of Osteoporosis in Postmenopausal Women with Type 2 Diabetes Mellitus. Central European Journal of Public Health, 25, 3-10. [Google Scholar] [CrossRef] [PubMed]
[4] 中华医学会. 原发性骨质疏松症基层诊疗指南(2019年) [J]. 中华全科医师杂志, 2020, 19(4): 304-315.
[5] Lane, N.E. (2006) Epidemiology, Etiology, and Diagnosis of Osteoporosis. American Journal of Obstetrics & Gynecology, 194, S3-S11. [Google Scholar] [CrossRef] [PubMed]
[6] Cummings, S.R., Browner, W.S., Bauer, D., et al. (1998) Endogenous Hormones and the Risk of Hip and Vertebral Fractures among Older Women. The New England Journal of Medicine, 339, 733-738. [Google Scholar] [CrossRef
[7] Hannan, M.T., Felson, D.T., Dawson-Hughes, B., et al. (2000) Risk Factors for Longitudinal Bone Loss in Elderly Men and Women: The Framingham Osteoporosis Study. Journal of Bone & Mineral Research, 15, 710-720. [Google Scholar] [CrossRef] [PubMed]
[8] Mihara, M., Hashizume, M., Yoshida, H., et al. (2012) IL-6/IL-6 Receptor System and Its Role in Physiological and Pathological Conditions. Clinical Science, 122, 143-159. [Google Scholar] [CrossRef
[9] Chaabo, K. and Kirkham, B. (2015) Rheumatoid Arthritis—Anti-TNF. International Immunopharmacology, 27, 180-184. [Google Scholar] [CrossRef] [PubMed]
[10] Mori, T., Miyamoto, T., Yoshida, H., et al. (2011) IL-1β and TNFα-Initiated IL-6-STAT3 Pathway Is Critical in Mediating Inflammatory Cytokines and RANKL Expression in Inflammatory Arthritis. International Immunology, 23, 701-712. [Google Scholar] [CrossRef] [PubMed]